aluates Reports

$ 0.0

Automative

Meningococcal Group B Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-20E12305

Global Meningococcal Group B Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Meningococcal Group B Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-20E12305

Report

September 2024

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Pfizer Inc

Meningococcal Group B Vaccine - Market Size

The global market for Meningococcal Group B Vaccine was estimated to be worth US$ 1107 million in 2023 and is forecast to a readjusted size of US$ 2034.2 million by 2030 with a CAGR of 8.6% during the forecast period 2024-2030

Meningococcal Group B Vaccine - Market

Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meningococcal Group B Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Meningococcal Group B Vaccine by region & country, by Type, and by Application.

The Meningococcal Group B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Group B Vaccine.

Market Segmentation

Scope of Meningococcal Group B Vaccine - Market Report

Report Metric	Details
Report Name	Meningococcal Group B Vaccine - Market
Forecasted market size in 2030	US$ 2034.2 million
CAGR	8.6%
Forecasted years	2024 - 2030
Segment by Type:	Bexsero Trumenba Other
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Meningococcal Group B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Meningococcal Group B Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Meningococcal Group B Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Meningococcal Group B Vaccine - Market size in 2030?

Ans: The Meningococcal Group B Vaccine - Market size in 2030 will be US$ 2034.2 million.

Who are the main players in the Meningococcal Group B Vaccine - Market report?

Ans: The main players in the Meningococcal Group B Vaccine - Market are GSK, Pfizer

What are the Application segmentation covered in the Meningococcal Group B Vaccine - Market report?

Ans: The Applications covered in the Meningococcal Group B Vaccine - Market report are Public, Private

What are the Type segmentation covered in the Meningococcal Group B Vaccine - Market report?

Ans: The Types covered in the Meningococcal Group B Vaccine - Market report are Bexsero, Trumenba, Other

Recommended Reports

Meningococcal Vaccines

Pediatric Vaccines

Vaccine Technologies

1 Market Overview

1.1 Meningococcal Group B Vaccine Product Introduction

1.2 Global Meningococcal Group B Vaccine Market Size Forecast

1.2.1 Global Meningococcal Group B Vaccine Sales Value (2019-2030)

1.2.2 Global Meningococcal Group B Vaccine Sales Volume (2019-2030)

1.2.3 Global Meningococcal Group B Vaccine Sales Price (2019-2030)

1.3 Meningococcal Group B Vaccine Market Trends & Drivers

1.3.1 Meningococcal Group B Vaccine Industry Trends

1.3.2 Meningococcal Group B Vaccine Market Drivers & Opportunity

1.3.3 Meningococcal Group B Vaccine Market Challenges

1.3.4 Meningococcal Group B Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Meningococcal Group B Vaccine Players Revenue Ranking (2023)

2.2 Global Meningococcal Group B Vaccine Revenue by Company (2019-2024)

2.3 Global Meningococcal Group B Vaccine Players Sales Volume Ranking (2023)

2.4 Global Meningococcal Group B Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Meningococcal Group B Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Meningococcal Group B Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Meningococcal Group B Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Meningococcal Group B Vaccine

2.9 Meningococcal Group B Vaccine Market Competitive Analysis

2.9.1 Meningococcal Group B Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Meningococcal Group B Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Group B Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Bexsero

3.1.2 Trumenba

3.1.3 Other

3.2 Global Meningococcal Group B Vaccine Sales Value by Type

3.2.1 Global Meningococcal Group B Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Meningococcal Group B Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Meningococcal Group B Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Meningococcal Group B Vaccine Sales Volume by Type

3.3.1 Global Meningococcal Group B Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Meningococcal Group B Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Meningococcal Group B Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Meningococcal Group B Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Public

4.1.2 Private

4.2 Global Meningococcal Group B Vaccine Sales Value by Application

4.2.1 Global Meningococcal Group B Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Meningococcal Group B Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Meningococcal Group B Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Meningococcal Group B Vaccine Sales Volume by Application

4.3.1 Global Meningococcal Group B Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Meningococcal Group B Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Meningococcal Group B Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Meningococcal Group B Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Meningococcal Group B Vaccine Sales Value by Region

5.1.1 Global Meningococcal Group B Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Meningococcal Group B Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Meningococcal Group B Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Meningococcal Group B Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Meningococcal Group B Vaccine Sales Volume by Region

5.2.1 Global Meningococcal Group B Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Meningococcal Group B Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Meningococcal Group B Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Meningococcal Group B Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Meningococcal Group B Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Meningococcal Group B Vaccine Sales Value, 2019-2030

5.4.2 North America Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Meningococcal Group B Vaccine Sales Value, 2019-2030

5.5.2 Europe Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Meningococcal Group B Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Meningococcal Group B Vaccine Sales Value, 2019-2030

5.7.2 South America Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Meningococcal Group B Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Meningococcal Group B Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Meningococcal Group B Vaccine Sales Value

6.2.1 Key Countries/Regions Meningococcal Group B Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Meningococcal Group B Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Meningococcal Group B Vaccine Sales Value, 2019-2030

6.3.2 United States Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Meningococcal Group B Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Meningococcal Group B Vaccine Sales Value, 2019-2030

6.4.2 Europe Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Meningococcal Group B Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Meningococcal Group B Vaccine Sales Value, 2019-2030

6.5.2 China Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Meningococcal Group B Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Meningococcal Group B Vaccine Sales Value, 2019-2030

6.6.2 Japan Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Meningococcal Group B Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Meningococcal Group B Vaccine Sales Value, 2019-2030

6.7.2 South Korea Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Meningococcal Group B Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Meningococcal Group B Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Meningococcal Group B Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Meningococcal Group B Vaccine Sales Value, 2019-2030

6.9.2 India Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Meningococcal Group B Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GSK

7.1.1 GSK Company Information

7.1.2 GSK Introduction and Business Overview

7.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GSK Meningococcal Group B Vaccine Product Offerings

7.1.5 GSK Recent Development

7.2 Pfizer

7.2.1 Pfizer Company Information

7.2.2 Pfizer Introduction and Business Overview

7.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Pfizer Meningococcal Group B Vaccine Product Offerings

7.2.5 Pfizer Recent Development

8 Industry Chain Analysis

8.1 Meningococcal Group B Vaccine Industrial Chain

8.2 Meningococcal Group B Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Meningococcal Group B Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Meningococcal Group B Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

GSK

Pfizer Inc

List of Tables

Table 1. Meningococcal Group B Vaccine Market Trends

Table 2. Meningococcal Group B Vaccine Market Drivers & Opportunity

Table 3. Meningococcal Group B Vaccine Market Challenges

Table 4. Meningococcal Group B Vaccine Market Restraints

Table 5. Global Meningococcal Group B Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Meningococcal Group B Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Meningococcal Group B Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Meningococcal Group B Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Meningococcal Group B Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Meningococcal Group B Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Meningococcal Group B Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Meningococcal Group B Vaccine

Table 13. Global Meningococcal Group B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Group B Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Meningococcal Group B Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Meningococcal Group B Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Meningococcal Group B Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Meningococcal Group B Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Meningococcal Group B Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Meningococcal Group B Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Meningococcal Group B Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Meningococcal Group B Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Meningococcal Group B Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Meningococcal Group B Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Meningococcal Group B Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Meningococcal Group B Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Meningococcal Group B Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Meningococcal Group B Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Meningococcal Group B Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Meningococcal Group B Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Meningococcal Group B Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Meningococcal Group B Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Meningococcal Group B Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Meningococcal Group B Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Meningococcal Group B Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Meningococcal Group B Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Meningococcal Group B Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Meningococcal Group B Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Meningococcal Group B Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Meningococcal Group B Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Meningococcal Group B Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Meningococcal Group B Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Meningococcal Group B Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Meningococcal Group B Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Meningococcal Group B Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Meningococcal Group B Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Meningococcal Group B Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Meningococcal Group B Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Meningococcal Group B Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Meningococcal Group B Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Meningococcal Group B Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Meningococcal Group B Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Meningococcal Group B Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Meningococcal Group B Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Meningococcal Group B Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. GSK Company Information

Table 58. GSK Introduction and Business Overview

Table 59. GSK Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. GSK Meningococcal Group B Vaccine Product Offerings

Table 61. GSK Recent Development

Table 62. Pfizer Company Information

Table 63. Pfizer Introduction and Business Overview

Table 64. Pfizer Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Pfizer Meningococcal Group B Vaccine Product Offerings

Table 66. Pfizer Recent Development

Table 67. Key Raw Materials Lists

Table 68. Raw Materials Key Suppliers Lists

Table 69. Meningococcal Group B Vaccine Downstream Customers

Table 70. Meningococcal Group B Vaccine Distributors List

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

List of Figures

Figure 1. Meningococcal Group B Vaccine Product Picture

Figure 2. Global Meningococcal Group B Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Meningococcal Group B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Meningococcal Group B Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Meningococcal Group B Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Meningococcal Group B Vaccine Report Years Considered

Figure 7. Global Meningococcal Group B Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Meningococcal Group B Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Meningococcal Group B Vaccine Revenue in 2023

Figure 10. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Bexsero Picture

Figure 12. Trumenba Picture

Figure 13. Other Picture

Figure 14. Global Meningococcal Group B Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Meningococcal Group B Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Meningococcal Group B Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Meningococcal Group B Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Meningococcal Group B Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 19. Product Picture of Public

Figure 20. Product Picture of Private

Figure 21. Global Meningococcal Group B Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Meningococcal Group B Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Meningococcal Group B Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Meningococcal Group B Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Meningococcal Group B Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Meningococcal Group B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Meningococcal Group B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Meningococcal Group B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Meningococcal Group B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Meningococcal Group B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Meningococcal Group B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Meningococcal Group B Vaccine Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Meningococcal Group B Vaccine Sales Volume (%), (2019-2030)

Figure 38. United States Meningococcal Group B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Meningococcal Group B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Meningococcal Group B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Meningococcal Group B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 44. China Meningococcal Group B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 46. China Meningococcal Group B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Meningococcal Group B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Meningococcal Group B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Meningococcal Group B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Meningococcal Group B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Meningococcal Group B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Meningococcal Group B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 56. India Meningococcal Group B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Meningococcal Group B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 58. India Meningococcal Group B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 59. Meningococcal Group B Vaccine Industrial Chain

Figure 60. Meningococcal Group B Vaccine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Vaccine for Non infectious Meningitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Meningitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Meningococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Meningococcal Infections Vaccine Market Insights Forecast to 2030

Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Haemophilus Influenzae Type B Vaccine Market Insights Forecast to 2030

Meningococcal Meningitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Meningococcal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Meningococcal Infections Treatment Market Research Report 2024

Global Vaccines For Children Market Insights Forecast to 2030

Hib Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Meningococcal Group A and C Conjugate Vaccine Market Research Report 2024

Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2024

Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Meningococcal Polysaccharide Vaccine Market Research Report 2025

Global Streptococcus Group B Antibodies Market Research Report 2024

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumococcal Vaccination Market Research Report 2025

Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions